SeaCrest Wealth Management LLC Decreases Stock Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

SeaCrest Wealth Management LLC reduced its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 2.2% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 17,173 shares of the company’s stock after selling 391 shares during the period. SeaCrest Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $1,612,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Swedbank AB grew its stake in GE HealthCare Technologies by 6.6% during the third quarter. Swedbank AB now owns 72,013 shares of the company’s stock worth $6,758,000 after buying an additional 4,490 shares during the period. Wesbanco Bank Inc. grew its stake in GE HealthCare Technologies by 14.6% during the third quarter. Wesbanco Bank Inc. now owns 17,027 shares of the company’s stock worth $1,598,000 after buying an additional 2,175 shares during the period. Armstrong Advisory Group Inc. grew its stake in GE HealthCare Technologies by 32.0% during the third quarter. Armstrong Advisory Group Inc. now owns 1,255 shares of the company’s stock worth $118,000 after buying an additional 304 shares during the period. Douglas Lane & Associates LLC grew its stake in GE HealthCare Technologies by 2.2% during the third quarter. Douglas Lane & Associates LLC now owns 460,004 shares of the company’s stock worth $43,171,000 after buying an additional 10,099 shares during the period. Finally, Exchange Traded Concepts LLC lifted its position in shares of GE HealthCare Technologies by 1.7% during the third quarter. Exchange Traded Concepts LLC now owns 10,676 shares of the company’s stock worth $1,002,000 after purchasing an additional 175 shares in the last quarter. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CEO Thomas J. Westrick sold 2,750 shares of the stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the sale, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at $1,414,377.02. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.27% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on GEHC shares. Evercore ISI boosted their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a research report on Monday, September 9th. They set a “neutral” rating and a $90.00 target price on the stock. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price target for the company from $84.00 to $74.00 in a report on Thursday, September 26th. Finally, Stifel Nicolaus upped their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a report on Monday, September 30th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, seven have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies has an average rating of “Moderate Buy” and a consensus price target of $94.23.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock traded down $0.09 during trading on Wednesday, hitting $90.62. 45,426 shares of the stock were exchanged, compared to its average volume of 3,024,270. The stock’s fifty day moving average is $87.37 and its 200 day moving average is $83.31. The stock has a market cap of $41.36 billion, a PE ratio of 26.52, a P/E/G ratio of 3.39 and a beta of 1.18. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The firm had revenue of $4.84 billion during the quarter, compared to analyst estimates of $4.88 billion. During the same quarter in the prior year, the firm posted $0.92 EPS. GE HealthCare Technologies’s revenue was up .5% compared to the same quarter last year. As a group, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.13%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.